Bio-inorganic chemistry at PSL

This series of seminar is presented by M. Fontecave (Collège de France), G. Casser (Chimie ParisTech), Clotilde Policar (ENS) and Raphaël Rodriguez (Institut Curie).

This seminar is founded by PSL (ANR 10-IDEX-0001-02).

Program:

2019, February, Friday 8^th 4:30 PM:

• Eva Toth, Centre de Biophysique Moléculaire, Orléans: Molecular imaging agents based on lanthanide complexes

2019, February, Friday 15^th 4:30 PM:

• Lionel Chéruzel, San Jose State University: Hybrid P450 Enzymes Featuring Ru(II)-diimine Complexes

2019, March, Friday 22^nd 4:30 PM:

• Martin Stillman, Univeristy of Western Ontario: Pushing native ESI-MS to the limite : Believing in metallation binding constants and rate constants for the metallation of metallothioneins

2019, April, Monday 8^th 4:30 PM:

• Thibaud Rossel, Gymnase français de Bienne: Indicator displacement assays: A versatile tool for education and research

2019, April, Wednesday 10^th afternoon (time to be announced later) - Tutorial and seminar:

• David Giedroc, Indiana University:
  • Tutorial: Leveraging biophysical and bioinorganic chemistry to investigate bacterial transition metal homeostasis
  • Seminar: From molecules to metabolism: Elucidating the bacterial adaptive response to host-mediated transition metal starvation

2019, May, 4:30 PM (schedule not yet available):

• Liz Nolan, Massachussets Institute of Technology (MIT): Metals and Immunity: Bioinorganic Explorations of Calprotectin

2019, July, Thursday 4th 4:30 PM:

• Daniella Buccella, New York University: Fluorescent tools and strategies for the study of cellular magnesium

2019, July Friday 5th 4:30 PM:

• Raphaël Tripier, Université de Bretagne Occidentale (UBO): Highly performant azamacrocyclic chelates tailored for diagnosis and therapy: Full control of the ligand design makes the difference!

2019, September (schedule not yet available):

• Inès Batinic-Haberle, Duke University: Mn porphyrins, commonly known as SOD mimics, act as radioprotectors of normal tissue and anticancer agents via thiol signaling